title: Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.
authors.forename: Vasilios
authors.initials: V
authors.lastname: Perifanis
authors.forename: Timos
authors.initials: T
authors.lastname: Vyzantiadis
authors.forename: Sofia
authors.initials: S
authors.lastname: Vakalopoulou
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tziomalos
authors.forename: Vasilia
authors.initials: V
authors.lastname: Garypidou
authors.forename: Miranta
authors.initials: M
authors.lastname: Athanassiou-Metaxa
authors.forename: Fedon
authors.initials: F
authors.lastname: Harsoulis
mesh_terms: D000328:Adult; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D000077211:Zoledronic Acid; D017086:beta-Thalassemia / Q000150:complications*
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D007334:Insulin-Like Growth Factor I; D000077211:Zoledronic Acid